BAY3630942
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BAY3630942, covering 2025-04-13 to 2025-04-13. Get the full timeline:
Most recent: Clinical Trial Update: A First-in-Human Study to Learn About How BAY3630942 is Distributed and Processed Inside the Body When Given After BAY3547922 and How Safe it is in People With Liver Cancer or Other Select Solid Cancers [Phase 1]